Pro Medicus Limited (FRA:PMC)

Pro Medicus Statistics

Total Valuation

Pro Medicus has a market cap or net worth of EUR 12.61 billion. The enterprise value is 12.49 billion.

Market Cap	12.61B
Enterprise Value	12.49B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	Sep 3, 2025

Share Statistics

Current Share Class	104.47M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	48.67%
Owned by Institutions (%)	14.68%
Float	53.04M

Valuation Ratios

The trailing PE ratio is 196.02 and the forward PE ratio is 138.91.

PE Ratio	196.02
Forward PE	138.91
PS Ratio	106.04
PB Ratio	87.89
P/TBV Ratio	95.62
P/FCF Ratio	203.67
P/OCF Ratio	202.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 137.00, with an EV/FCF ratio of 201.73.

EV / Earnings	194.16
EV / Sales	102.13
EV / EBITDA	137.00
EV / EBIT	137.86
EV / FCF	201.73

Financial Position

The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.01.

Current Ratio	6.49
Quick Ratio	6.38
Debt / Equity	0.01
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 51.82% and return on invested capital (ROIC) is 43.93%.

Return on Equity (ROE)	51.82%
Return on Assets (ROA)	33.09%
Return on Invested Capital (ROIC)	43.93%
Return on Capital Employed (ROCE)	53.38%
Revenue Per Employee	900,729
Profits Per Employee	487,273
Employee Count	132
Asset Turnover	0.71
Inventory Turnover	4.20

Taxes

In the past 12 months, Pro Medicus has paid 26.85 million in taxes.

Income Tax	26.85M
Effective Tax Rate	29.45%

Stock Price Statistics

The stock price has decreased by -22.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.36%
50-Day Moving Average	136.92
200-Day Moving Average	152.35
Relative Strength Index (RSI)	40.49
Average Volume (20 Days)	94

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pro Medicus had revenue of EUR 118.90 million and earned 64.32 million in profits. Earnings per share was 0.61.

Revenue	118.90M
Gross Profit	118.72M
Operating Income	88.08M
Pretax Income	91.17M
Net Income	64.32M
EBITDA	88.27M
EBIT	88.08M
Earnings Per Share (EPS)	0.61

Balance Sheet

The company has 117.60 million in cash and 1.26 million in debt, with a net cash position of 116.34 million.

Cash & Cash Equivalents	117.60M
Total Debt	1.26M
Net Cash	116.34M
Net Cash Per Share	n/a
Equity (Book Value)	143.45M
Book Value Per Share	1.37
Working Capital	132.28M

Cash Flow

In the last 12 months, operating cash flow was 62.15 million and capital expenditures -245,072, giving a free cash flow of 61.91 million.

Operating Cash Flow	62.15M
Capital Expenditures	-245,072
Free Cash Flow	61.91M
FCF Per Share	n/a

Margins

Gross margin is 99.85%, with operating and profit margins of 74.09% and 54.10%.

Gross Margin	99.85%
Operating Margin	74.09%
Pretax Margin	76.68%
Profit Margin	54.10%
EBITDA Margin	74.24%
EBIT Margin	74.09%
FCF Margin	52.07%

Dividends & Yields

This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 0.25%.

Dividend Per Share	0.32
Dividend Yield	0.25%
Dividend Growth (YoY)	31.56%
Years of Dividend Growth	9
Payout Ratio	42.63%
Buyback Yield	-0.01%
Shareholder Yield	0.25%
Earnings Yield	0.51%
FCF Yield	0.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pro Medicus has an Altman Z-Score of 170.27 and a Piotroski F-Score of 4.

Altman Z-Score	170.27
Piotroski F-Score	4